ヘルスケアにおけるイノベーションは、質の高いデータから、いかに意味のある生物学的知見を導き出せるかに大きく左右されます。特殊シリコン技術やセンシング技術の進歩により、生体プロセスをこれまでにない精度・連続性・スケールでモニタリングすることが可能になりつつあり、ライフサイエンスから医療機器まで、新たな可能性が広がっています。

バイオものづくりにおけるリアルタイムモニタリングとプロセス制御、MPS（生体模倣システム）によるヒトへの予測性を高めたデータの取得、さらには生体信号を検知・解析し、それに応じて機能するインテリジェント医療機器まで、センシング技術は未来のヘルスケアを支える重要な基盤となりつつあります。 データ解析、マイクロ流体、半導体工学などの技術革新と組み合わせることで、生体データを実用的な知見へと変換し、研究開発の加速、医療アウトカムの向上、さらには新たな製品や治療法の創出につながることが期待されています。

Japan Health Symposium 2026では、産業界・アカデミア・研究機関の専門家が一堂に会し、センシング技術の革新が半導体・バイオロジー・データサイエンスの融合をどのように加速しているのか、そして分野を越えた連携が次世代のヘルスケアソリューションをどのように形づくっていくのかを議論します。

Why attend?

本シンポジウムは半日の日程で開催され、終了後にはネットワーキング・レセプションを予定しています。ライフサイエンス、バイオ医薬品、医療機器の各分野において、センシング技術の進歩がどのような新たなアプローチを可能にしているのかを探ります。

本シンポジウムでは、以下のような知見を得る機会になります。

シリコンベースのセンサーが、基礎研究・創薬から医療機器、患者モニタリングまで、ヘルスケアの幅広い領域にもたらす新たな可能性を知る
リアルタイムの生体データが、より高度で適応性・拡張性の高いヘルスケアソリューションをどのように実現するのかを学ぶ
バイオものづくり、ヒト生体模倣システム（MPS／Organ-on-Chip）、次世代医療機器など、新たな応用領域への理解を深める
半導体技術、センシングプラットフォーム、データ解析の進歩が、生体信号を実用的な知見へとどのように変換しているのかを知る
センシング技術の革新を通じてヘルスケアの未来を切り拓く、産業界・アカデミア・研究機関のリーダーとのネットワークを構築する

本シンポジウムには、技術開発企業、ヘルスケア・ライフサイエンス関連企業、医療機器メーカー、研究者、イノベーションを牽引するリーダーが集います。先端センシング技術の具体的な活用方法と、それらが未来のヘルスケアにもたらす可能性について、ともに考える機会を提供します。

Agenda

Language: simultaneous interpretation will be provided throughout the symposium in English and Japanese.

13:00 - Registration
13:30 - Welcome & opening remarks
- Katrien Marent, EVP & Chief Marketing and Communications Officer at imec
- Hiroshi Saigusa, CEO at RISE-A; Senior Advisor at LINK-J; and Fellow (Innovation) at Mitsui Fudosan
13:45 - Bringing the power of semiconductor technologies to healthcare and life sciences by Liesbet Lagae, R&D Fellow, Health, at imec
14:05 - Accelerating healthcare innovation through partnership by Miranda Noblesse, Business Line Director, Health, at imec

Panels & deep dives

14:20 - Manufacturing biology with smart silicon
Exploring how advanced sensing technologies can enable real-time monitoring and control of biomanufacturing processes for advanced therapies.
- Moderator: Olivier Henry, Program Director, Life Sciences and Medical Device Technologies at imec
- Speakers: Tomoyoshi Tokumaru (PHC), Yusuke Tomozoe (Hitachi High-Tech)
15:15 - Coffee break
15:45 - Closing the loop: silicon-miniaturized intelligence at the body interface
Examining how next-generation sensing technologies are enabling closed-loop medical devices that can monitor, interpret and respond to physiological signals in real time.
- Moderator: Patrick van Deursen, Senior Director, Health Sector, imec
- Speakers: Takufumi Yanagisawa (The University of Osaka), Munemasa Sugimoto (INOPASE Inc.)
16:35 - Human biology on chip: the next big thing in personalised medicine
Discussing how sensing-enabled microphysiological systems are creating more predictive, human-relevant models for drug discovery and development.
- Moderator: Olivier Henry, Program Director, Life Sciences and Medical Device Technologies at imec
- Speakers: Kazuo Takayama (Institute of Science Tokyo), Ichiro Miki (Physios Biotech), Yoshikazu Kameda (Physios Biotech), Masaya Hagiwara (RIKEN)
17:20 - Closing & networking reception
19:00 - End

Speakers

Katrien Marent - EVP & Chief Marketing and Communications Officer, imec

Katrien Marent became imec's VP Corporate, Marketing and Outreach Communication in 2016. Since April 2020, she is Executive Vice President & Chief Marketing and Communications Officer, and member of the executive board of imec. Katrien has an engineering degree in microelectronics. She joined imec in 1992 as an analog design engineer and specialized in design of low-noise readout electronics for high-energy physics.

Hiroshi Saigusa - CEO, RISE-A; Senior Advisor, LINK-J; Fellow (Innovation), Mitsui Fudosan Co., Ltd.

Hiroshi Saigusa is CEO of RISE-A, Senior Advisor of LINK-J, and Fellow (Innovation) at Mitsui Fudosan Co., Ltd. Since joining Mitsui Fudosan in 1989, he has held a range of leadership roles across planning, research, and urban development. He currently leads initiatives that strengthen collaboration across Japan's life sciences and innovation ecosystem through his roles at LINK-J and RISE-A.

Liesbet Lagae - R&D Fellow, Health, imec

Liesbet Lagae is R&D Fellow for Health at imec. She co-founded imec's Life Science Technologies activities and has played a key role in advancing the application of semiconductor technologies in healthcare and life sciences. Her work focuses on developing chip-based solutions for diagnostics, genomics, cellular technologies, neurotechnologies, and other emerging health applications. She is also a professor in nanobiophysics at KU Leuven.

Miranda Noblesse - Business Line Director, Health, imec

Miranda Noblesse is Business Line Director of Health at imec, where she leads the business strategy and growth of imec’s health portfolio. She brings over 20 years of leadership experience in life sciences, spanning medical devices, digital healthcare and clinical diagnostics. Before joining imec in 2023, she held senior roles at Materialise, B. Braun Medical, bioMérieux and Roche Diagnostics Belgium

Olivier Henry - Program Director, Life Sciences and Medical Device Technologies, imec

Olivier Henry is Program Director, Life Sciences and Medical Device Technologies at imec. He leads multidisciplinary innovation programs at the intersection of biosensing, microfluidics, organ-on-chip technologies, advanced biomanufacturing and semiconductor innovation. He works with pharmaceutical and technology partners to develop R&D programs addressing challenges in healthcare and biopharma.

Tomoyoshi Tokumaru - General Manager, Cell Processing Solution Development Department, PHC Corporation

Tomoyoshi Tokumaru leads Cell & Gene Therapy development at PHC Corporation, driving the commercialization of the LiCellMo live cell metabolic analyzer and LiCellGrow cell expansion system. He joined SANYO Electric Co., Ltd. in 1999 and began his career in robotics R&D before moving into the life sciences field, where he led the development of CO₂ incubators and automated cell culture systems. He also serves as Chair of the Facilities and Equipment Committee of FIRM.

Yusuke Tomozoe - General Manager, Cell & Gene Therapy Solution Department, Hitachi High-Tech Corporation

Yusuke Tomozoe leads the Cell & Gene Therapy Solution Department at Hitachi High-Tech Corporation. Since 2016, he has been involved in the commercialization of automated cell culture technologies, including iACE2. Based on collaborative research between Kyoto University, Sumitomo Pharma and Hitachi, he led the commercialization of automated cell culture systems and consumables for manufacturing iPS cell-derived dopaminergic neural progenitor cells.

Patrick van Deursen - Senior Director, Health Sector, imec

Patrick van Deursen is Senior Director of the Health Sector at imec. Together with his teams, he focuses on the development and commercialization of MedTech R&D for medical and health devices. Previously, he served as Business Development Director at Philips, where he led European home healthcare initiatives with a focus on e-health. Patrick holds a degree in Mechanical Engineering from Delft University of Technology and an MBA from Rotterdam School of Management.

Takufumi Yanagisawa - Professor, The University of Osaka

Takufumi Yanagisawa is Professor of Neuroinformatics at The University of Osaka and holds a concurrent appointment in the Department of Neurosurgery. Following training in neurosurgery, he engaged in the development of brain-computer interfaces using electrocorticography and received his PhD in Medicine from Osaka University in 2009. He has held his current position since November 2024.

Munemasa Sugimoto - Co-founder & CEO, INOPASE, Inc.

Munemasa Sugimoto is co-founder and CEO of INOPASE Inc. Before co-founding the company in 2021, he worked at KPMG AZSA LLC, Novartis Pharma K.K. and CDI Medical, Inc. He also participated in the Japan Biodesign Fellowship Program at the University of Tokyo from 2019 to 2020. He holds degrees from Keio University and Washington University in St. Louis.

Kazuo Takayama - Professor, Institute of Science Tokyo

Kazuo Takayama is Professor at Institute of Science Tokyo. His research focuses on developing human organ models using pluripotent stem cell-derived organoids and microphysiological systems, including organ-on-a-chip technologies. His group develops models of the intestine, liver, lung and blood-brain barrier for applications in drug discovery and disease modelling.

Ichiro Miki - CEO, Physios Biotech, Inc.

Ichiro Miki is CEO of Physios Biotech, Inc. Prior to assuming his current position in 2024, he held leadership and program management roles at Kyowa Hakko Kogyo Co., Ltd., JST, RIKEN and AMED. At Kyowa Hakko, he worked in drug discovery research and later served as Director of Drug Discovery Research Laboratories.

Yoshikazu Kameda - Board Director & COO, Physios Biotech, Inc.

Yoshikazu Kameda is Board Director and COO of Physios Biotech, Inc. While at Kyoto University, he conducted research on microphysiological systems for the vascularization of kidney organoids under the supervision of Professor Ryuji Yokokawa. He received his PhD in Engineering from Kyoto University in 2025, joined Physios Biotech in 2024 as Director of Research and Development, and assumed his current role in June 2026.

Masaya Hagiwara - Team Director, RIKEN

Masaya Hagiwara is Team Director at RIKEN, a position he has held since 2019. His research focuses on developing engineering technologies to reconstitute biological systems outside the body. With a background spanning automobile manufacturing and microrobotics, he develops technologies that control cellular microenvironments and model interactions between tissues and organs.

Location

Nihonbashi Life Science HUB
Nihonbashi Muromachi, 1-5-5, Chuo-ku,
Tokyo 103-0022, 8F.,
Muromachi Chibagin Mitsui Building

Please take the elevator to the 8th floor. Signs will direct you to the room.

Organizing partners

先端センシングが創るヘルスケアの未来

About